Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tiotropium Bromide,Inapplicable
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase I
Recipient : Xiromed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 12, 2024
Lead Product(s) : Tiotropium Bromide,Inapplicable
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase I
Recipient : Xiromed
Deal Size : Inapplicable
Deal Type : Inapplicable